<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002884'>Hepatoblastoma</z:hpo> is commonly associated with loss of heterozygosity (LOH) involving chromosome region 11p15.5 </plain></SENT>
<SENT sid="1" pm="."><plain>This region may contain an as yet unidentified <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor gene relevant to this and other <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> associated with the <z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Beckwith-Wiedemann syndrome</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Using the insulin (INS) locus as a marker for this region we have identified two of three patients with <z:hpo ids='HP_0002884'>hepatoblastoma</z:hpo> whose livers demonstrated genetic mosaicism </plain></SENT>
<SENT sid="3" pm="."><plain>One <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> arose from the clone demonstrating LOH in the liver while the other arose from the clone without LOH </plain></SENT>
</text></document>